간편하게 보는 뉴스는 유니콘뉴스
ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors

· 등록일 Dec. 07, 2023 14:30

· 업데이트일 2023-12-07 15:02:49

CAMBRIDGE, MASS.--(Business Wire / Korea Newswire)--ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Paul Perreault to its Board of Directors, effective December 5, 2023. Mr. Perreault most recently served as Chief Executive Officer of CSL and brings over 40 years of leadership experience across the biotechnology industry.

“Paul is a distinguished industry executive recognized for his extensive track record in drug development and was integral to the growth of CSL to become an international leader in the field. His leadership and extensive knowledge of the biotech industry will be an invaluable addition to our company as we continue to build our portfolio of novel RNA medicines,” said Amit D. Munshi, Chief Executive Officer of ReNAgade. “We are pleased to welcome Paul to the ReNAgade team and look forward to his contributions.”

“I am thrilled to join ReNAgade at this exciting time for the company,” said Mr. Perreault. “ReNAgade is led by a world-class executive team, and its innovative technologies have the potential to drive the field of RNA medicines forward on an unprecedented scale in the coming years.”

Mr. Perreault brings more than 40 years of experience in the global biotechnology and pharmaceutical industries, most recently as CEO and Managing Director of CSL. Within his 25-year career with CSL, he was responsible for operations in more than 40 countries, including major manufacturing sites in the U.S., Switzerland, Germany and Australia, and an extensive network of plasma collection centers throughout North America and Germany. He previously served in senior leadership roles at various companies in the space including Wyeth, Centeon, Aventis Bioservices and Aventis Behring, and served on the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA). In 2019, Mr. Perreault was included in Harvard Business Review’s CEO 100 List and recognized as one of the best performing CEOs in the world. He earned his B.S. in Psychology from the University of Central Florida and completed advanced business management training at Kellogg School of Management and Wharton School of the University of Pennsylvania.

About ReNAgade Therapeutics

ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing, and gene insertion to develop new medicines.

To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines.

ReNAgade Therapeutics—RNA Without Limits

For more information about the company, its technologies, and its leadership, visit www.renagadetx.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20231205970464/en/

Website: https://renagadetx.com/ View Korean version of this release Contact ReNAgade Therapeutics
Investor Relations
Argot Partners
Emily Brabbit
(212) 600-1902
renagade@argotpartners.com

Media Relations
Argot Partners
Sarah Sutton
(212) 600-1902
renagade@argotpartners.com
This news is a press release from the provider.
Korea Newswire is committed to verifying the transparency of providers and eliminating content errors.
You can receive press releases from this company or in industries of interest via email and RSS for free. Subscribe> News provided byReNAgade Therapeutics Distribution Channel Health Pharmaceutical Biotechnology Personnel anouncement Overseas
인기 기사04.07 22시 기준
서울--(뉴스와이어)--로봇의 A부터 Z까지 모든 것을 만나볼 수 있는 ‘2024 로보월드(ROBOTWORLD)’가 개최를 앞두고 참가 업체를 대상으로 조기 신청 할인을 진행한다. 2024 로보월드 사전 홍보 영상 ...
서울--(뉴스와이어)--무용교육의 지평을 넓히고 우리나라 무용예술의 방향을 제시하며 미래상을 추구하는 선구자인 이화여자대학교 무용과(이하 이화 무용과)가 올해로 60돌을 맞이했다. ‘2023 MOVEMENT EWHA’ 공연 포스터 ...
서울--(뉴스와이어)--토탈뷰티살롱 청담 뮤아이(대표원장 이수진, www.instagram.com/muu.i_official_)가 퍼스널컬러 컨설팅 서비스 강화에 나섰다. 왼쪽부터 청담 뮤아이 김정민 원장, 이수진 대표 원장 청담 뮤아이는...
서울--(뉴스와이어)--피아니스트 이여경이 프랑스 ‘파리’를 주제로 2024년 1월 6일(토) 예술의전당 리사이틀홀에서 독주회 ‘À Paris’를 연다. 피아니스트 이여경 ...
서울--(뉴스와이어)--최근 발표된 딜로이트 글로벌 CEO 대상 서베이에 따르면 글로벌 대표 기업 최고 경영자(CxO)들은 경기 불황 전망 속에서도 2024년 경영 기조를 성장관리(Managing Growth)로 삼으면서 자사 성장에 대해 낙관적 전망을 견지하고 있다. 이들의 성장에 대한 낙관적...
창원--(뉴스와이어)--DN솔루션즈가 동남아시아 시장 공략을 강화하기 위해 베트남 법인 ‘DN솔루션즈 비나(DN Solutions Vina)’를 설립했다고 4일 밝혔다. DN솔루션즈가 동남아시아 시장 공략을 강화하기 위해 베트남 법인 ‘DN Solutions...
API
fg
유니콘뉴스는 보도자료 배포 서비스입니다.
여기에 뉴스를 등록하면 언론이 보도하고 널리 배포됩니다.